Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 1 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 2 |
Descriptor
Cognitive Ability | 2 |
Adults | 1 |
Age Differences | 1 |
Auditory Perception | 1 |
COVID-19 | 1 |
Comparative Analysis | 1 |
Control Groups | 1 |
Dementia | 1 |
Depression (Psychology) | 1 |
Disease Control | 1 |
Diseases | 1 |
More ▼ |
Author
Asgari, Karim | 1 |
Charlotte R. Pennington | 1 |
Chitsaz, Ahmad | 1 |
Christopher J. Plack | 1 |
Emsaki, Golit | 1 |
Helen E. Nuttall | 1 |
Kate Slade | 1 |
Molavi, Hossein | 1 |
Robert Davies | 1 |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
Beck Depression Inventory | 2 |
Beck Anxiety Inventory | 1 |
What Works Clearinghouse Rating
Kate Slade; Robert Davies; Charlotte R. Pennington; Christopher J. Plack; Helen E. Nuttall – Journal of Speech, Language, and Hearing Research, 2023
Purpose: In March 2020, the U.K. government announced that people should isolate to reduce the spread of the virus that causes COVID-19. Outside a pandemic, psychosocial factors, such as socialization and mental health, may impact the relationship between hearing loss and increased dementia risk. We aim to report the impact of psychosocial…
Descriptors: Foreign Countries, COVID-19, Pandemics, Disease Control
Emsaki, Golit; Asgari, Karim; Molavi, Hossein; Chitsaz, Ahmad – Psicologica: International Journal of Methodology and Experimental Psychology, 2013
In the present study, the effectiveness of 3 drug regimen on cognitive performance of PD patients was compared. 12 patients who had been using pramipexole, levodopa and amantadine for at least 1 month entered the study and compared with those 12 who had been using trihexiphenidyle, levodopa and amantadine. There was also a control group…
Descriptors: Drug Therapy, Diseases, Neurological Impairments, Patients